Sivers Semiconductors Braces for a Three-Way Test: Restated Accounts, Index Entry, and a Board Overhaul

Swedish chip maker Sivers faces pivotal moment with restated losses, MSCI inclusion, planned 15% dilution, and dual Nasdaq listing amid short seller pressure.

When Sivers Semiconductors publishes its first-quarter results on 29 May, it will be doing so under the gaze of at least three powerful constituencies: index fund managers forced to buy the stock, short sellers pressing their bets, and the company's own shareholders facing a potential 15% dilution from a planned capital increase. The confluence of events marks a pivotal moment for the Swedish chip developer as it races to satisfy US audit standards and secure a dual listing on the Nasdaq.

The headline numbers have already been rewritten. In its restated annual report for 2025, compiled to meet American GAAP, the company reported a net loss of SEK 222.6 million, up sharply from the originally stated SEK 186.5 million. The operating loss widened to SEK 177.8 million from SEK 141.3 million. While 2025 revenue held steady at SEK 306.6 million, the 2024 top line was revised downward to SEK 219.2 million from SEK 243.7 million, and equity shrank to SEK 949.8 million from roughly SEK 1.08 billion.

The accounting overhaul was triggered by adjustments to revenue recognition, inventory valuation, and capitalised development costs — purely bookkeeping changes, the company says, but ones that have deepened the red ink. The restatement has also delayed the quarterly report, originally expected earlier, to 29 May. That date coincides with the MSCI Sweden Small Cap Index rebalancing, after which Sivers shares will be automatically added to the benchmark. Passive funds tracking the index are expected to snap up the stock, a dynamic that helped fuel a recent rally of more than 30%.

Yet the optimism surrounding the AI-driven photonics story — Sivers' optical chips address heat problems in data centres and the stock trades at 46 times sales — sits uncomfortably alongside a series of headwinds. On 11 May, an extraordinary general meeting approved a targeted share issue of 8.62 million new shares at SEK 14.50 each to institutional investors. A second, larger capital raise is now on the table for the annual general meeting on 15 June, which could dilute existing holders by roughly 15%. The AGM will also vote on an options programme covering up to 7 million instruments, and no dividend is proposed.

The meeting will see significant boardroom changes. Vice-chairman Tomas Duffy and board members Erik Fällström and Keith Halsey are set to depart. Joakim Nideborn has been nominated as the new vice-chair, with Helena Svancar proposed as a new member. Bami Bastani is expected to be re-elected as chair.

Institutional bears remain active. Hedge funds Voleon and Two Sigma hold substantial short positions against the stock, and an additional overhang comes from the largest single shareholder, Achilles Capital, whose parent company is undergoing a restructuring. That could trigger an uncontrolled block sale. Adding to the uncertainty, the Swedish Economic Crime Authority is investigating whether details of the US listing plans leaked prematurely.

The market has not ignored the combination of deepening losses and looming dilution. On Friday, the stock slid 4.7% to around SEK 54, partly reversing the sharp gains of the preceding days. The 29 May report will be the first under the new accounting framework and the clearest signal yet of whether Sivers can sustain its Nasdaq ambitions without further financial shocks.